F
$ Value
$15K
Shares
2,217
Price
$7
Filed
Aug 8
Insider
Name
Rottinghaus Scott T.
Title
Chief Medical Officer
CIK
0001942407
Roles
Officer
Transaction Details
Transaction Date
2025-08-08
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,590
Footnotes
Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on August 8, 2022.
Filing Info
Rottinghaus Scott T.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | A | $0 |
| 2026-02-12 | ENTA | F | $49K |
| 2025-12-05 | ENTA | ▼ | $11K |
| 2025-11-25 | ENTA | A | $0 |
| 2025-08-08 | ENTA | F | $15K |
Other Insiders at ENTA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER BRUCE L A | — | — | 2026-03-11 |
| FOLETTA MARK G | — | — | 2026-03-11 |
| Russell Lesley | — | — | 2026-03-11 |
| Peterson Kristine | — | — | 2026-03-11 |
|
Luly Jay R.
President and CEO
|
— | — | 2026-02-12 |
|
Or Yat Sun
Chief Scientific Officer
|
— | — | 2026-02-12 |
| Vance Terry | — | — | 2026-03-11 |
| Hata Yujiro S | — | — | 2026-03-11 |
|
Kowalsky Matthew Paul
Chief Legal Officer
|
— | — | 2026-02-12 |
|
Kieffer Tara Lynn
Chief Product Strategy Officer
|
— | — | 2026-02-12 |
|
Luu Brendan
Chief Business Officer
|
— | — | 2026-02-12 |
|
Rottinghaus Scott T.
Chief Medical Officer
|
— | — | 2026-02-12 |